The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension
- PMID: 2031471
- DOI: 10.1007/BF01418518
The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension
Abstract
In five head-injured patients with cerebral contusion and oedema in whom it was not possible to control intracranial pressure (ICP) (ICP greater than 20 mmHg) by artificial hyperventilation (PaCO2 level 3.5-4.0 kPa) and barbiturate sedation, indomethacin was used as a vasoconstrictor drug. In all patients, indomethacin (a bolus injection of 30 mg, followed by 30 mg/h for seven hours) reduced ICP below 20 mmHg for several hours. Studies of cerebral circulation and metabolism during indomethacin treatment showed a decrease in CBF at 2 h. After 7 h, ICP remained below 20 mmHg in three patients, and these still had reduced CBF. In the other patients a return of ICP and CBF to pretreatment levels was observed. In all patients indomethacin treatment was followed by a fall in rectal temperature. These results suggest that indomethacin due to its cerebral vasoconstrictor and antipyretic effect should be considered as an alternative for treatment of ICP-hypertension in head-injured patients.
Similar articles
-
Indomethacin (Confortid) in severe head injury and elevated intracranial pressure (ICP).Acta Neurochir Suppl (Wien). 1992;55:47-8. doi: 10.1007/978-3-7091-9233-7_14. Acta Neurochir Suppl (Wien). 1992. PMID: 1414545
-
[Indomethacin in severe cerebral contusions with intracranial hypertension].Cah Anesthesiol. 1990;38(8):530-2. Cah Anesthesiol. 1990. PMID: 2094567 French.
-
Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report.J Neurosurg. 1995 Oct;83(4):627-30. doi: 10.3171/jns.1995.83.4.0627. J Neurosurg. 1995. PMID: 7674011
-
Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients.Neurol Res. 1999 Jul;21(5):491-9. Neurol Res. 1999. PMID: 10439431 Review.
-
[Effects of anesthetic agents on intracranial pressure].Ann Fr Anesth Reanim. 1997;16(4):445-52. doi: 10.1016/s0750-7658(97)81477-3. Ann Fr Anesth Reanim. 1997. PMID: 9750596 Review. French.
Cited by
-
Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".Neurocrit Care. 2005;2(1):83-95. doi: 10.1385/NCC:2:1:083. Neurocrit Care. 2005. PMID: 16174975 Review.
-
Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury.J Cereb Blood Flow Metab. 2014 Oct;34(10):1585-98. doi: 10.1038/jcbfm.2014.131. Epub 2014 Jul 23. J Cereb Blood Flow Metab. 2014. PMID: 25052556 Free PMC article. Review.
-
Indomethacin for control of ICP.Neurocrit Care. 2015 Jun;22(3):437-49. doi: 10.1007/s12028-014-0088-3. Neurocrit Care. 2015. PMID: 25450721
-
Head injury.J Neurol Neurosurg Psychiatry. 1993 May;56(5):440-7. doi: 10.1136/jnnp.56.5.440. J Neurol Neurosurg Psychiatry. 1993. PMID: 8505631 Free PMC article. Review. No abstract available.
-
Therapy of intracranial hypertension in patients with fulminant hepatic failure.Neurocrit Care. 2006;4(2):179-89. doi: 10.1385/NCC:4:2:179. Neurocrit Care. 2006. PMID: 16627910 Review.